Advertisement
Screener

Immunocore Holdings plc (IMCR) Auditor

Immunocore Holdings plc Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-25: Fiscal year end 2025-12-31; Auditor Deloitte LLP; PCAOB firm ID 1147; Location Cambridge, United Kingdom.
  • 2025-02-26: Fiscal year end 2024-12-31; Auditor Deloitte LLP; PCAOB firm ID 1147; Location Cambridge, United Kingdom.
  • 2024-02-28: Fiscal year end 2023-12-31; Auditor Deloitte LLP; PCAOB firm ID 1147; Location Cambridge, United Kingdom.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-252025-12-31Deloitte LLP1147Cambridge, United KingdomYes
2025-02-262024-12-31Deloitte LLP1147Cambridge, United KingdomYes
2024-02-282023-12-31Deloitte LLP1147Cambridge, United KingdomYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Vericel Corp (VCEL)United States$2.011B93.97
Replimune Group, Inc. (REPL)United States$1.186B-3.13
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12